有样本,需要委托检测
带上研究问题、样本类型、数量与分组,讨论靶标检测和项目评估。
了解SIMOA服务沟通检测项目SIMOA / ASSAY
Simoa® Neurology 4-Plex E 是一款用于神经退行性疾病和脑损伤研究的超敏多因子检测试剂盒,可在 EDTA 血浆和脑脊液样本中同时检测 Aβ40、Aβ42、GFAP 和 NfL 四个神经相关生物标志物。适用于阿尔茨海默病、神经损伤、药物研发和临床转化研究中的低丰度蛋白检测。 The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are amyloid beta 40 (Aβ40),…

The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are amyloid beta 40 (Aβ40), amyloid beta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP), and Neurofilament light (NfL). With this Neuro 4-Plex E kit we introduce novel amyloid beta 40 and amyloid beta 42 assays developed for highly specific and sensitive measurement of the concentrations of full-length amyloid beta 1-42 and amyloid beta 1-40. This improved specificity for full-length amyloid beta 1-42 and amyloid beta 1-40 is expected to be increasingly important to target specific amyloid beta isoforms and for target engagement in future clinical trials.
*Banyan GFAP™ is a registered trademark of Banyan Biomarkers01 / DESCRIPTION
The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are amyloid beta 40 (Aβ40), amyloid beta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP), and Neurofilament light (NfL). With this Neuro 4-Plex E kit we introduce novel amyloid beta 40 and amyloid beta 42 assays developed for highly specific and sensitive measurement of the concentrations of full-length amyloid beta 1-42 and amyloid beta 1-40. This improved specificity for full-length amyloid beta 1-42 and amyloid beta 1-40 is expected to be increasingly important to target specific amyloid beta isoforms and for target engagement in future clinical trials.
*Banyan GFAP™ is a registered trademark of Banyan Biomarkers
The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. Each biomarker has been demonstrated to have significance for the investigation of neurodegeneration and brain injury, and to have utility for monitoring effectiveness of drug discovery and development for neurological disease.
The assay kit includes all necessary reagents and controls to perform 96 tests, making it easy to use and compatible with various sample types.
02 / DOCUMENTATION
保留原有原厂资料入口。不同仪器与版本的参数,请逐一核对对应文件。
03 / CITATIONS
通过 Bioz 查看这款产品的引用文献、应用摘要与研究图片。
Bioz 实时文献组件 · 可在组件内筛选和滚动浏览;无法载入时可在 Bioz 打开。
NEXT STEP / 两条实验路径
带上研究问题、样本类型、数量与分组,讨论靶标检测和项目评估。
了解SIMOA服务沟通检测项目说明现有仪器、目标标记和实验条件,确认试剂、资料与适配范围。
浏览完整 Assay 目录咨询试剂与实验配置